CPO SEC-arkivering - - Årsrapport, fuldmagtserklæring, prospekt

Grundlæggende statistik

LEI	PKSTQ48QDN0XSVS7YK88
CIK	1046257

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to

SEC Filings (Chronological Order)

Denne side giver en komplet, kronologisk liste over SEC-arkiveringer, eksklusive ejerskabsregistreringer, som vi leverer andre steder.

May 21, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2026 INGREDION INCORPORAT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2026 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission File
May 14, 2026	EX-99.1	NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. Exhibit 99.1 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE “CODE”) AND DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF TH
May 14, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2026 INGREDION INCORPORAT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2026 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission File
May 8, 2026	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13397 INGREDION IN
May 8, 2026	EX-10.1	Ingredion Incorporated Stock Incentive Plan Global Restricted Stock Unit Award Agreement Exhibit 10.1 Ingredion Incorporated Stock Incentive Plan Global Restricted Stock Unit Award Agreement Pursuant to this Global Restricted Stock Unit Award Agreement (individually and collectively with any Addendum, this “Award Agreement”), Ingredion Incorporated (the “Company”) has granted you an award of Restricted Stock Units (“Award”) under the Ingredion Incorporated Stock Incentive Plan (as may
May 5, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2026 INGREDION INCORPORATE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2026 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission File N
May 5, 2026	EX-99	INGREDION INCORPORATED REPORTS FIRST QUARTER 2026 RESULTS PRESS RELEASE Ingredion Incorporated CONTACTS: 5 Westbrook Corporate Center Investors: Noah Weiss, 773-896-5242 Westchester, IL 60154 Media: Rick Wion, 708-209-6323 INGREDION INCORPORATED REPORTS FIRST QUARTER 2026 RESULTS •First quarter 2026 reported and adjusted* operating income decreased 26% and 22% compared to the first quarter 2025 •First quarter 2026 reported and adjusted EPS were $2.
May 5, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 5, 2026 INGREDION INCORPORATED UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 5, 2026 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
April 8, 2026	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 8, 2026	ARS	ARS a2025ingrannualreportvfi
April 8, 2026	DEF 14A	DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 8, 2026	ARS	ARS
March 25, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2026 INGREDION INCORPOR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2026 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission Fil
March 23, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2026 INGREDION INCORPOR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2026 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission Fil
February 17, 2026	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13397 INGREDION INCORPO
February 17, 2026	EX-10.6	1 Ingredion Incorporated Stock Incentive Plan Global Performance Share Agreement Pursuant to this Global Performance Share Agreement (this “Award Agreement”) and its accompanying Notice of Grant of Performance Shares (the “Grant Notice”), Ingredion I ingr-20251231xex106 1 Ingredion Incorporated Stock Incentive Plan Global Performance Share Agreement Pursuant to this Global Performance Share Agreement (this “Award Agreement”) and its accompanying Notice of Grant of Performance Shares (the “Grant Notice”), Ingredion Incorporated (the “Company”) has granted the Participant an award of Performance Shares (this “Award”) under the Ingredion Incorporated Stock Incentive Plan (as may be amended from time to time, the “Plan”).
February 17, 2026	EX-24.1	INGREDION INCORPORATED EXHIBIT 24.1 INGREDION INCORPORATED POWER OF ATTORNEY Form 10-K for the Fiscal Year Ended December 31, 2025 KNOW ALL MEN BY THESE PRESENTS, that I, as a director of Ingredion Incorporated, a Delaware corporation (the “Company”), do hereby constitute and appoint Tanya M. Jaeger de Foras as my true and lawful attorney-in-fact and agent, for me and in my name, place and stead, to sign the Annual Repo
February 17, 2026	EX-97.1	INGREDION INCORPORATED POLICY ON RECOUPMENT OF INCENTIVE COMPENSATION Effective Date: January 1, 2014 Restatement Effective Date: October 27, 2023 Exhibit 97.1 INGREDION INCORPORATED POLICY ON RECOUPMENT OF INCENTIVE COMPENSATION Effective Date: January 1, 2014 Restatement Effective Date: October 27, 2023 Subject to the terms of this Policy set forth below, the People, Culture and Compensation Committee (the “Committee”) of the Board of Directors of Ingredion Incorporated (the “Company”) may or shall, as applicable, require the return, repay
February 17, 2026	EX-10.4	INGREDION INCORPORATED NON-QUALIFIED DEFERRED COMPENSATION PLAN AMENDED AND RESTATED EFFECTIVE JANUARY 1, 2026 FOREWORD Effective as of January 1, 1998, Ingredion Incorporated (formerly Corn Products International, Inc.) has adopted the Ingredion Inc ingr-20251231xex104 INGREDION INCORPORATED NON-QUALIFIED DEFERRED COMPENSATION PLAN AMENDED AND RESTATED EFFECTIVE JANUARY 1, 2026 FOREWORD Effective as of January 1, 1998, Ingredion Incorporated (formerly Corn Products International, Inc.
February 17, 2026	EX-21.1	SUBSIDIARIES OF THE REGISTRANT EXHIBIT 21.1 SUBSIDIARIES OF THE REGISTRANT The Registrant’s subsidiaries as of February 17, 2026, are listed below showing the percentage of voting securities directly or indirectly owned by the Registrant. All other subsidiaries, if considered in the aggregate as a single subsidiary, would not constitute a significant subsidiary. Percentage of voting securities directly or indirectly owned by th
February 17, 2026	EX-10.18	1 Ingredion Incorporated Stock Incentive Plan Global Restricted Stock Unit Award Agreement Pursuant to this Global Restricted Stock Unit Award Agreement (individually and collectively with any Addendum, this “Award Agreement”), Ingredion Incorporated ingr-20251231xex1018 1 Ingredion Incorporated Stock Incentive Plan Global Restricted Stock Unit Award Agreement Pursuant to this Global Restricted Stock Unit Award Agreement (individually and collectively with any Addendum, this “Award Agreement”), Ingredion Incorporated (the “Company”) has granted you an award of Restricted Stock Units (“Award”) under the Ingredion Incorporated Stock Incentive Plan (as may be amended from time to time, the “Plan”).
February 17, 2026	EX-10.26	Summary of Non-Employee Director Compensation Exhibit 10.26 Summary of Non-Employee Director Compensation The following summary describes the individual components of the non-employee director compensation of Ingredion Incorporated (the “Company”) in 2026. Effective January 1, 2026, each non-employee director is entitled to an annual retainer of $275,000, which consists of (i) an annual cash retainer of $105,000, paid in four equal quarterly
February 3, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 3, 2026 INGREDION INCORPOR UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 3, 2026 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
February 3, 2026	EX-99	INGREDION INCORPORATED REPORTS 2025 FOURTH QUARTER AND FULL-YEAR RESULTS Exhibit 99 NEWS RELEASE Ingredion Incorporated 5 Westbrook Corporate Center CONTACTS: Westchester, IL 60154 Investors: Noah Weiss, 773-896-5242 Media: Rick Wion, 708-209-6323 INGREDION INCORPORATED REPORTS 2025 FOURTH QUARTER AND FULL-YEAR RESULTS •Reported and adjusted* EPS were $11.
January 27, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2026 INGREDION INCORP UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2026 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission F
November 7, 2025	EX-25.1	= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION D Exhibit 25.1 = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) ☐ THE BANK OF NEW
November 7, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13397 INGREDIO
November 7, 2025	S-3ASR	As filed with the Securities and Exchange Commission on November 7, 2025 As filed with the Securities and Exchange Commission on November 7, 2025 Registration No.
November 7, 2025	EX-FILING FEES	Security Type Calculation of Filing Fee Tables S-3 Ingredion Inc Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial Effective Date Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward Newly Registered Securities Fees to be Paid 1 Debt Debt securities 457(r) 0.
November 4, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 4, 2025 INGREDION INCORPOR UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 4, 2025 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
November 4, 2025	EX-99	INGREDION INCORPORATED REPORTS THIRD QUARTER 2025 RESULTS PRESS RELEASE Ingredion Incorporated CONTACTS: 5 Westbrook Corporate Center Investors: Noah Weiss, 773-896-5242 Westchester, IL 60154 Media: Rick Wion, 708-209-6323 INGREDION INCORPORATED REPORTS THIRD QUARTER 2025 RESULTS •Third quarter 2025 reported and adjusted* operating income decreased 7% and 10% compared to the third quarter 2024 •Third quarter 2025 reported and adjusted EPS were $2.
November 4, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2025 INGREDION INCORP UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2025 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission F
September 29, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 25, 2025 INGREDION INCO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 25, 2025 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission
August 28, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2025 INGREDION INCORPO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2025 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission Fi
August 28, 2025	EX-10.1	REVOLVING CREDIT AGREEMENT dated as of August 27, 2025 INGREDION INCORPORATED, The Subsidiary Borrowers Party Hereto, The Lenders Party Hereto, JPMORGAN CHASE BANK, N.A. and J.P. MORGAN SE, as Administrative Agent BANK OF AMERICA, N.A., CITIBANK, N.A Exhibit 10.1 EXECUTION VERSION REVOLVING CREDIT AGREEMENT dated as of August 27, 2025 among INGREDION INCORPORATED, The Subsidiary Borrowers Party Hereto, The Lenders Party Hereto, JPMORGAN CHASE BANK, N.A. and J.P. MORGAN SE, as Administrative Agent and BANK OF AMERICA, N.A., CITIBANK, N.A., and PNC BANK, NATIONAL ASSOCIATION, as Co-Syndication Agents JPMORGAN CHASE BANK, N.A., BOFA SECURITIES, I
August 11, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13397 INGREDION INC
August 1, 2025	EX-99	INGREDION INCORPORATED DELIVERS SOLID SECOND QUARTER RESULTS AND IMPROVES FULL-YEAR OUTLOOK PRESS RELEASE Ingredion Incorporated 5 Westbrook Corporate Center CONTACTS: Westchester, IL 60154 Investors: Noah Weiss, 773-896-5242 Media: Rick Wion, 708-209-6323 INGREDION INCORPORATED DELIVERS SOLID SECOND QUARTER RESULTS AND IMPROVES FULL-YEAR OUTLOOK •Second quarter 2025 reported and adjusted* operating income increased 13% and 1% compared to prior year •Second quarter 2025 reported and adjusted EPS were $2.
August 1, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 1, 2025 INGREDION INCORPORAT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 1, 2025 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
June 30, 2025	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D C.
June 30, 2025	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) [X] Annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2024 or [ ] Transition report pursuant to Section 15(d) of the Securities Exchange Act o
May 23, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2025 INGREDION INCORPORAT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2025 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission File
May 9, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13397 INGREDION IN
May 9, 2025	EX-10.1	Letter of Agreement, dated as of November 12, 2021, between Ingredion and Tanya Jaeger de Foras. T. Jaeger de Foras Page 1 Ingredion Incorporated 5 Westbrook Corporate Center Westchester, IL 60154 PERSONAL & CONFIDENTIAL November 12, 2021 Tanya Jaeger de Foras Delivered electronically UPDATED Dear Tanya: Congratulations! I am pleased to confirm our offer of employment to join Ingredion Incorporated in the position of Chief Legal Officer, Corporate Secretary and Chief Compliance Officer, with
May 9, 2025	EX-10.2	Letter of Agreement, dated as of April 16, 2023, between Ingredion and Robert Ritchie. exhibit102 1 Ingredion Incorporated 5 Westbrook Corporate Center Westchester, IL 60154 PERSONAL & CONFIDENTIAL April 16, 2023 Robert Ritchie Delivered electronically Dear Rob: Congratulations! I am pleased to confirm your appointment to the position of Senior Vice President, Food and Industrial Ingredients Americas, with an effective date of May 2, 2023.
May 6, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2025 INGREDION INCORPORATE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2025 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission File N
May 6, 2025	EX-99	INGREDION INCORPORATED REPORTS STRONG FIRST QUARTER RESULTS AND IMPROVES FULL-YEAR OUTLOOK PRESS RELEASE Ingredion Incorporated 5 Westbrook Corporate Center CONTACTS: Westchester, IL 60154 Investors: Noah Weiss, 773-896-5242 Media: Rick Wion, 708-209-6323 INGREDION INCORPORATED REPORTS STRONG FIRST QUARTER RESULTS AND IMPROVES FULL-YEAR OUTLOOK •First quarter 2025 reported and adjusted* operating income increased 30% and 26% compared to prior year •First quarter 2025 reported and adjusted EPS were $3.
May 6, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 6, 2025 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
April 9, 2025	ARS	ARS INGREDION 2024 ANNUAL REPORT Better Texture for Better Health 2024 ANNUAL REPORT Better Texture for Better Health Better Texture for Better HealthIngredion’s success over our 115+ year history comes directly from our commitment to be what’s next™ for our customers.
April 9, 2025	DEF 14A	DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 9, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
February 20, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13397 INGREDION INCORPO
February 20, 2025	EX-19.1	Insider Trading Compliance Policy. INGREDION INCORPORATED INSIDER TRADING COMPLIANCE POLICY Purpose This Insider Trading Compliance Policy (this “Policy”) provides guidelines with respect to transactions in the securities of Ingredion Incorporated (the “Company”) and the securities of other entities about which material nonpublic information is obtained in the course of service with the Company.
February 20, 2025	EX-10.11	Form of 2025 Stock Option Award Agreement for use in connection with awards under the 2023 Stock Incentive Plan. 1 Ingredion Incorporated Stock Incentive Plan Global Stock Option Award Agreement Pursuant to this Global Stock Option Award Agreement (individually and collectively with any Addendum, this “Award Agreement”), Ingredion Incorporated (the “Company”) has granted you a Non-Qualified Stock Option (the “Option”) under the Ingredion Incorporated Stock Incentive Plan (as may be amended from time to time, the “Plan”).
February 20, 2025	EX-10.31	Summary of Non-Employee Director Compensation. Exhibit 10.31 Summary of Non-Employee Director Compensation The following summary describes the individual components of the non-employee director compensation of Ingredion Incorporated (the "Company") in 2025. As compared to calendar year 2024, there are no changes in the amount of annual cash or equity retainer and there are no changes in the amount of the additional retainers for the Chairman o
February 20, 2025	EX-10.2	Amendment No. 1 to Stock Incentive Plan as effective October 15, 2024. Ingredion Incorporated 2023 Stock Incentive Plan (Effective May 19, 2023) Amendment No.
February 20, 2025	EX-10.5	Amendment No. 7 to Supplemental Executive Retirement Plan as effective December 31, 2023. Exhibit 10.5
February 20, 2025	EX-10.26	Amendment to each form of Executive Severance Agreement as filed as Exhibits 10.24 and 10.25. AMENDMENT TO SEVERANCE AGREEMENT THIS AMENDMENT (the “Amendment”), dated as of , 2024 (the “Effective Date”), is entered into between [NAME] (“Executive”) and INGREDION INCORPORATED, an Illinois corporation (the “Company”) (collectively the “Parties”).
February 20, 2025	EX-10.4	Supplemental Executive Retirement Plan, effective as of January 1, 1998, as last amended and restated on November 27, 2017. INGREDION INCORPORATED SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN EFFECTIVE JANUARY 1, 1998 AMENDED AND RESTATED EFFECTIVE AS OF JANUARY 1, 2001 1 1 As amended by Amendment No.
February 20, 2025	EX-10.8	Form of 2025 Performance Share Award Agreement for use in connection with awards under the 2023 Stock Incentive Plan. 1 Ingredion Incorporated Stock Incentive Plan Global Performance Share Agreement Pursuant to this Global Performance Share Agreement (this “Award Agreement”) and its accompanying Notice of Grant of Performance Shares (the “Grant Notice”), Ingredion Incorporated (the “Company”) has granted the Participant an award of Performance Shares (this “Award”) under the Ingredion Incorporated Stock Incentive Plan (as may be amended from time to time, the “Plan”).
February 20, 2025	EX-24.1	Power of Attorney EXHIBIT 24.1 INGREDION INCORPORATED POWER OF ATTORNEY Form 10-K for the Fiscal Year Ended December 31, 2024 KNOW ALL MEN BY THESE PRESENTS, that I, as a director of Ingredion Incorporated, a Delaware corporation (the “Company”), do hereby constitute and appoint Tanya M. Jaeger de Foras as my true and lawful attorney-in-fact and agent, for me and in my name, place and stead, to sign the Annual Repo
February 20, 2025	EX-97.1	Policy on Recoupment of Incentive Compensation as restated as of October 27, 2023. Exhibit 97.1 INGREDION INCORPORATED POLICY ON RECOUPMENT OF INCENTIVE COMPENSATION Effective Date: January 1, 2014 Restatement Effective Date: October 27, 2023 Subject to the terms of this Policy set forth below, the People, Culture and Compensation Committee (the “Committee”) of the Board of Directors of Ingredion Incorporated (the “Company”) may or shall, as applicable, require the return, repay
February 20, 2025	EX-10.21	Form of 2025 Restricted Stock Units Award Agreement for use in connection with awards under the 2023 Stock Incentive Plan. 1 Ingredion Incorporated Stock Incentive Plan Global Restricted Stock Unit Award Agreement Pursuant to this Global Restricted Stock Unit Award Agreement (individually and collectively with any Addendum, this “Award Agreement”), Ingredion Incorporated (the “Company”) has granted you an award of Restricted Stock Units (“Award”) under the Ingredion Incorporated Stock Incentive Plan (as may be amended from time to time, the “Plan”).
February 20, 2025	EX-21.1	Subsidiaries of the Registrant EXHIBIT 21.1 SUBSIDIARIES OF THE REGISTRANT The Registrant’s subsidiaries as of February 20, 2025, are listed below showing the percentage of voting securities directly or indirectly owned by the Registrant. All other subsidiaries, if considered in the aggregate as a single subsidiary, would not constitute a significant subsidiary. Percentage of voting securities directly or indirectly owned by th
February 4, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 4, 2025 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
February 4, 2025	EX-99	INGREDION INCORPORATED REPORTS STRONG 2024 FOURTH QUARTER AND FULL-YEAR RESULTS Exhibit 99 NEWS RELEASE Ingredion Incorporated 5 Westbrook Corporate Center CONTACTS: Westchester, IL 60154 Investors: Noah Weiss, 773-896-5242 Media: Rick Wion, 708-209-6323 INGREDION INCORPORATED REPORTS STRONG 2024 FOURTH QUARTER AND FULL-YEAR RESULTS •Full-year 2024 reported and adjusted* EPS were $9.
January 6, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 31, 2024 INGREDION INCORPO UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 31, 2024 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
November 14, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 14, 2024 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
November 14, 2024	EX-99	Texture Innovation Day November 14, 2024 Exhibit 99 2 Forward-Looking Statements This presentation contains or may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Texture Innovation Day November 14, 2024 Exhibit 99 2 Forward-Looking Statements This presentation contains or may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.
November 8, 2024	EX-10.3	Form of Amendment to Executive Severance Agreements entered into by certain executive officers of Ingredion to the agreements filed as Exhibits 10.17 and 10.18 to Ingredion’s Quarterly Report on Form 10-Q for the quarter ended Jun Exhibit 10.3 AMENDMENT TO SEVERANCE AGREEMENT This Amendment (the “Amendment”), dated as of , 2024 (the “Effective Date”), is entered into between [NAME] (“Executive”) and Ingredion Incorporated, an Illinois corporation (the “Company”) (collectively the “Parties”). RECITALS WHEREAS, Executive is party to that certain Ingredion Incorporated Executive Severance Agreement dated [DATE OF AGREEMENT] (t
November 8, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13397 INGREDIO
November 5, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 5, 2024 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
November 5, 2024	EX-99	INGREDION INCORPORATED REPORTS STRONG THIRD QUARTER RESULTS AND RAISES FULL-YEAR OUTLOOK Exhibit 99 NEWS RELEASE Ingredion Incorporated 5 Westbrook Corporate Center CONTACTS: Westchester, IL 60154 Investors: Noah Weiss, 773-896-5242 Media: Rick Wion, 708-209-6323 INGREDION INCORPORATED REPORTS STRONG THIRD QUARTER RESULTS AND RAISES FULL-YEAR OUTLOOK •Third quarter 2024 reported and adjusted* operating income increased 26% and 29% compared to prior year •Third quarter 2024 reported and adjusted EPS were $2.
September 10, 2024	SC 13G	INGR / Ingredion Incorporated / BlackRock Inc. Passive Investment us4571871023091024.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: ) INGREDION INCORPORATED - (Name of Issuer) Common Stock - (Title of Class of Securities) 457187102 - (CUSIP Number) August 31, 2024 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant t
August 8, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13397 INGREDION INC
August 6, 2024	EX-99	INGREDION INCORPORATED REPORTS STRONG SECOND QUARTER RESULTS AND RAISES FULL-YEAR OUTLOOK Exhibit 99 NEWS RELEASE Ingredion Incorporated 5 Westbrook Corporate Center CONTACTS: Westchester, IL 60154 Investors: Noah Weiss, 773-896-5242 Media: Rick Wion, 708-209-6323 INGREDION INCORPORATED REPORTS STRONG SECOND QUARTER RESULTS AND RAISES FULL-YEAR OUTLOOK •Second quarter 2024 reported and adjusted operating income* declined 4% and grew 8%, respectively, compared to prior year •Second quarter 2024 reported and adjusted EPS* were $2.
August 6, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 6, 2024 INGREDION INCORPORAT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 6, 2024 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
July 25, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 23, 2024 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission File
July 25, 2024	EX-10.1	Ingredion Incorporated Executive Severance Pay Plan Exhibit 10.1 Ingredion Incorporated Executive Severance Pay Plan and SUMMARY PLAN DESCRIPTION (“SPD”) The Ingredion Incorporated Executive Severance Pay Plan (the “Plan”) provides benefits to eligible executive employees, described in more detail below (“Participants”), whose employment is terminated under certain circumstances described in this Plan. If a Participant receives payments and benefit
July 25, 2024	EX-10.2	Ingredion Incorporated Executive Change in Control Severance Pay Plan Exhibit 10.2 Ingredion Incorporated Executive Change in Control Severance Pay Plan and SUMMARY PLAN DESCRIPTION (“SPD”) The Ingredion Incorporated Executive Change in Control Severance Pay Plan (the “Plan”) provides benefits to eligible executive employees, described in more detail below (“Participants”), whose employment is terminated under certain circumstances within two (2) years after a “Chan
June 25, 2024	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) [X] Annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2023 or [ ] Transition report pursuant to Section 15(d) of the Securities Exchange Act o
June 25, 2024	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D C.
May 16, 2024	8-K	Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2024 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission File
May 16, 2024	EX-3.1	Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Ingredion Incorporated CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF INGREDION INCORPORATED Ingredion Incorporated, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify that: 1.
May 9, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13397 INGREDION IN
May 8, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 8, 2024 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
May 8, 2024	EX-99	INGREDION COMPLETES REORGANIZATION, REPORTS FIRST QUARTER EARNINGS UNDER NEW SEGMENTS AND RAISES GUIDANCE Exhibit 99 NEWS RELEASE Ingredion Incorporated 5 Westbrook Corporate Center CONTACT: Westchester, IL 60154 Investors: Noah Weiss, 773-896-5242 Media: corpcomm@ingredion.
April 3, 2024	ARS	ARS 2023 ANNUAL REPORT Making Healthy Taste BetterIngredion performed exceptionally well and once again displayed resilience in 2023, delivering more than 20% operating income growth while expanding gross margins for six consecutive quarters.
April 3, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 3, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
March 22, 2024	PRE 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
February 27, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 22, 2024 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
February 21, 2024	EX-21.1	Subsidiaries of the Registrant EXHIBIT 21.1 SUBSIDIARIES OF THE REGISTRANT The Registrant’s subsidiaries as of February 20, 2024, are listed below showing the percentage of voting securities directly or indirectly owned by the Registrant. All other subsidiaries, if considered in the aggregate as a single subsidiary, would not constitute a significant subsidiary. Percentage of voting securities directly or indirectly owned by th
February 21, 2024	EX-10.26	Form of 2024 Performance Share Award Agreement for use in connection with awards under the 2023 Stock Incentive Plan. A-1 Ingredion Incorporated Stock Incentive Plan Global Performance Share Agreement Pursuant to this Global Performance Share Agreement (this “Award Agreement”) and its accompanying Notice of Grant of Performance Shares (the “Grant Notice”), Ingredion Incorporated (the “Company”) has granted the Participant an award of Performance Shares (this “Award”) under the Ingredion Incorporated Stock Incentive Plan (as may be amended from time to time, the “Plan”).
February 21, 2024	EX-24.1	Power of Attorney EXHIBIT 24.1 INGREDION INCORPORATED POWER OF ATTORNEY Form 10-K for the Fiscal Year Ended December 31, 2023 KNOW ALL MEN BY THESE PRESENTS, that I, as a director of Ingredion Incorporated, a Delaware corporation (the “Company”), do hereby constitute and appoint Tanya M. Jaeger de Foras as my true and lawful attorney-in-fact and agent, for me and in my name, place and stead, to sign the Annual Repo
February 21, 2024	EX-10.31	Letter of Agreement, dated April 16, 2023, between Ingredion and Jeremy Xu
February 21, 2024	EX-10.19	Form of 2024 Restricted Stock Units Award Agreement for use in connection with awards under the A-1 Ingredion Incorporated Stock Incentive Plan Global Restricted Stock Unit Award Agreement Pursuant to this Global Restricted Stock Unit Award Agreement (this “Award Agreement”) and its accompanying Award Certificate (as defined below), Ingredion Incorporated (the “Company”) has granted you an award of Restricted Stock Units (this “Award”) under the Ingredion Incorporated Stock Incentive Plan (as may be amended from time to time, the “Plan”).
February 21, 2024	EX-10.9	Form of 2024 Stock Option Award Agreement for use in connection with awards under the A-1 Ingredion Incorporated Stock Incentive Plan Global Stock Option Award Agreement Pursuant to this Global Stock Option Award Agreement (this “Award Agreement”) and its accompanying Award Certificate (as defined below), Ingredion Incorporated (the “Company”) has granted you a Non- Qualified Stock Option (the “Option”) under the Ingredion Incorporated Stock Incentive Plan (as may be amended from time to time, the “Plan”).
February 21, 2024	EX-10.29	Summary of Non-Employee Director Compensation. Exhibit 10.29 Summary of Non-Employee Director Compensation The following summary describes the individual components of the non-employee director compensation of Ingredion Incorporated (the "Company") in 2024. Effective January 1, 2024, each non-employee director is entitled to an annual retainer of $265,000 (an increase of $15,000 from the prior year), which is comprised of (i) an annual cash re
February 21, 2024	EX-97.1	Policy on Recoupment of Incentive Compensation as restated as of October 27, 2023. Exhibit 97.1 INGREDION INCORPORATED POLICY ON RECOUPMENT OF INCENTIVE COMPENSATION Effective Date: January 1, 2014 Restatement Effective Date: October 27, 2023 Subject to the terms of this Policy set forth below, the People, Culture and Compensation Committee (the “Committee”) of the Board of Directors of Ingredion Incorporated (the “Company”) may or shall, as applicable, require the return, repay
February 21, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13397 INGREDION INCORPO
February 13, 2024	SC 13G/A	INGR / Ingredion Incorporated / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01185-ingredioninc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 12)* Name of issuer: Ingredion Inc Title of Class of Securities: Common Stock CUSIP Number: 457187102 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the ru
February 6, 2024	EX-99	INGREDION INCORPORATED REPORTS STRONG 2023 FOURTH QUARTER AND FULL-YEAR RESULTS Exhibit 99 NEWS RELEASE Ingredion Incorporated 5 Westbrook Corporate Center CONTACTS: Westchester, IL 60154 Investors: Noah Weiss, 773-896-5242 Media: Becca Hary, 708-551-2602 INGREDION INCORPORATED REPORTS STRONG 2023 FOURTH QUARTER AND FULL-YEAR RESULTS •Fourth quarter 2023 reported and adjusted operating income* grew 29% and 21%, respectively •Full-year 2023 reported and adjusted EPS* were $9.
February 6, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 6, 2024 INGREDION INCORPOR UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 6, 2024 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
January 24, 2024	SC 13G/A	INGR / Ingredion Incorporated / BlackRock Inc. Passive Investment SC 13G/A 1 us4571871023012424.txt us4571871023012424.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 14) INGREDION INCORPORATED - (Name of Issuer) Common Stock - (Title of Class of Securities) 457187102 - (CUSIP Number) December 31, 2023 - (Date of Event Which Requires Filing of this Statement) Check the appropriat
November 13, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 10, 2023 INGREDION INCORPO UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 10, 2023 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
November 7, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 7, 2023 INGREDION INCORPOR UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 7, 2023 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
November 7, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13397 Ingredio
November 7, 2023	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 7, 2023 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
November 7, 2023	EX-99	INGREDION TO REALIGN ITS BUSINESS TO BETTER SERVE CUSTOMERS AND ENHANCE CLARITY FOR FINANCIAL STAKEHOLDERS Exhibit 99 NEWS RELEASE Ingredion Incorporated 5 Westbrook Corporate Center CONTACTS: Westchester, IL 60154 Investors: Noah Weiss, 773-896-5242 Media: Becca Hary, 708-551-2602 INGREDION TO REALIGN ITS BUSINESS TO BETTER SERVE CUSTOMERS AND ENHANCE CLARITY FOR FINANCIAL STAKEHOLDERS WESTCHESTER, Ill.
November 7, 2023	EX-99	INGREDION INCORPORATED REPORTS STRONG THIRD QUARTER RESULTS AND RAISES FULL-YEAR OUTLOOK Exhibit 99 NEWS RELEASE Ingredion Incorporated 5 Westbrook Corporate Center CONTACTS: Westchester, IL 60154 Investors: Noah Weiss, 773-896-5242 Media: Becca Hary, 708-551-2602 INGREDION INCORPORATED REPORTS STRONG THIRD QUARTER RESULTS AND RAISES FULL-YEAR OUTLOOK •Third quarter 2023 reported and adjusted operating income* grew 17% and 15%, respectively, compared to PY •Third quarter 2023 reported and adjusted EPS* were $2.
September 18, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 15, 2023 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission
August 8, 2023	EX-99	INGREDION INCORPORATED REPORTS STRONG SECOND QUARTER RESULTS AND RAISES FULL-YEAR OUTLOOK Exhibit 99 NEWS RELEASE Ingredion Incorporated 5 Westbrook Corporate Center CONTACTS: Westchester, IL 60154 Investors: Noah Weiss, 773-896-5242 Media: Becca Hary, 708-551-2602 INGREDION INCORPORATED REPORTS STRONG SECOND QUARTER RESULTS AND RAISES FULL-YEAR OUTLOOK •Second quarter 2023 reported and adjusted operating income* grew 18% and 17%, respectively, compared to PY •Second quarter 2023 reported and adjusted EPS* were $2.
August 8, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13397 Ingredion Inc
August 8, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 8, 2023 INGREDION INCORPORAT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 8, 2023 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
June 28, 2023	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) [X] Annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2022 or [ ] Transition report pursuant to Section 15(d) of the Securities Exchange Act o
June 28, 2023	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D C.
May 25, 2023	S-8	As filed with the Securities and Exchange Commission on May 25, 2023 S-8 As filed with the Securities and Exchange Commission on May 25, 2023 Registration Statement No.
May 25, 2023	EX-FILING FEES	Calculation of Filing Fee Tables. EX-FILING FEES Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Ingredion Incorporated (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price (2) Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.
May 23, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2023 INGREDION INCORPORAT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2023 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission File
May 23, 2023	EX-10.1	2023 Stock Incentive Plan, as effective May 19, 2023 (the “2023 Stock Incentive Plan”) (incorporated by reference to Exhibit 10.1 to Ingredion’s Current Report on Form 8-K dated May 19, 2023, filed on May 23, 2023) (File No. 1-13397) EX-10.1 Exhibit 10.1 INGREDION INCORPORATED 2023 STOCK INCENTIVE PLAN I. INTRODUCTION 1.1 Purposes. The purposes of the Ingredion Incorporated 2023 Stock Incentive Plan (this “Plan”) are (i) to align the interests of the stockholders of Ingredion Incorporated (the “Company”) and the recipients of awards under this Plan by increasing the proprietary interest of such recipients in the Company’s grow
May 8, 2023	EX-10.2	Revolving Credit Agreement, dated as of June 30, 2021, as amended, by and among Ingredion Incorporated, as Borrower, the Subsidiary Borrowers from time-to-time party thereto, the Lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent. EXECUTION COPY REVOLVING CREDIT AGREEMENT dated as of June 30, 2021 among INGREDION INCORPORATED, The Subsidiary Borrowers Party Hereto, The Lenders Party Hereto, JPMORGAN CHASE BANK, N.
May 8, 2023	EX-10.1	Letter of Agreement, dated as of November 1, 2021, between Ingredion and Nancy Wolfe (incorporated by reference to Exhibit 10.1 to Ingredion’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, filed on May 8, 2023) (File No. 1-13397). offerletterfullyexecuted XXX-XX-XXXX XXXXXXXX XX, XXXX
May 8, 2023	EX-10.1	Letter of Agreement, dated as of November 1, 2021, between Ingredion and Nancy Wolfe. EXHIBIT 10.1
May 8, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13397 Ingredion In
May 8, 2023	EX-10.2	Amendment No. 1 to Revolving Credit Agreement, dated as of November 30, 2022, by and among Ingredion Incorporated, as Borrower, the Subsidiary Borrowers from time-to-time party thereto, the Lenders from time-to-time party thereto and JP Morgan Chase Bank, N.A., as Administrative Agent (incorporated by reference to Exhibit 10.2 to Ingredion’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, filed on May 8, 2023) (File No. 1-13397). ex102-ingredion2022credi EXECUTION COPY REVOLVING CREDIT AGREEMENT dated as of June 30, 2021 among INGREDION INCORPORATED, The Subsidiary Borrowers Party Hereto, The Lenders Party Hereto, JPMORGAN CHASE BANK, N.
May 8, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13397 Ingredion In
May 3, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 3, 2023 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
May 3, 2023	EX-99	INGREDION INCORPORATED REPORTS RECORD FIRST QUARTER RESULTS AND RAISES FULL-YEAR OUTLOOK Exhibit 99 NEWS RELEASE Ingredion Incorporated 5 Westbrook Corporate Center CONTACTS: Westchester, IL 60154 Investors: Noah Weiss, 773-896-5242 Media: Becca Hary, 708-551-2602 INGREDION INCORPORATED REPORTS RECORD FIRST QUARTER RESULTS AND RAISES FULL-YEAR OUTLOOK •First quarter 2023 reported and adjusted EPS* were $2.
April 5, 2023	DEF 14A	Schedule 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 5, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) DEFA14A 1 d27251ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as per
April 3, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2023 INGREDION INCORPOR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2023 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission Fil
March 24, 2023	PRE 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
February 21, 2023	EX-10.9	Form of Amendment to 2022, March 2021, and February 2021 Performance Share Award Agreements, dated as of February 15, 2023 EXHIBIT 10.9 RAmendment to Performance Share Award Agreements Under the Ingredion Incorporated Stock Incentive Plan This Amendment to Award Agreements (this “Amendment”), entered into by Ingredion Incorporated (the “Company”) as of February 15, 2023, sets forth the terms pursuant to which the outstanding awards listed on Schedule A (the “Outstanding Awards”) granted to [NAME] (the “Participant”) u
February 21, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13397 INGREDION INCORPO
February 21, 2023	EX-3.2	Amended and Restated By-Laws of Ingredion EXHIBIT 3.2 AMENDED AND RESTATED BY-LAWS OF INGREDION INCORPORATED (the “Corporation”) ARTICLE I Offices SECTION 1.The registered office of the Corporation in the State of Delaware shall be in the City of Wilmington, County of New Castle, and the name of the registered agent of the Corporation in said State is The Corporation Trust Company. The Corporation may also have an office or offices other
February 21, 2023	EX-10.5	Form of 2023 Performance Share Award Agreement for use in connection with awards under the Stock Incentive Plan (incorporated by reference to Exhibit 10.5 to Ingredion’s Annual Report on Form 10-K for the year ended December 31, 2022, filed on February 21, 2023) (File No. 1-13397). EXHIBIT 10.5 Ingredion Incorporated Stock Incentive Plan Global Performance Share Agreement This Global Performance Share Agreement (including Exhibit 1 of the Grant Notice and Addendum hereto) (the “Award Agreement”), is made between Ingredion Incorporated (the “Company”) and the Participant, as set forth in the Grant Notice. The Grant Notice is included in, and made part of, this Award Agreement
February 21, 2023	EX-10.4	Annual Incentive Plan as effective January 1, 2022 (incorporated by reference to Exhibit 10.4 to Ingredion’s Annual Report on Form 10-K for the year ended December 31, 2022, filed on February 21, 2023) (File No. 1-13397). EXHIBIT 10.4 INGREDION INCORPORATED ANNUAL INCENTIVE PLAN EFFECTIVE JANUARY 1, 2022 Ingredion Incorporated (the “Company”) has previously established and maintained the Company’s Annual Incentive Plan (the “Plan”) and Short-Term Incentive Plan (“STIP”) for the benefit of eligible employees. The Company hereby amends and restates the Plan and the STIP in the form of this combined plan document effe
February 21, 2023	EX-10.32	Summary of Non-Employee Director Compensation. EX-10.32 11 ingr-20221231xex1032.htm EX-10.32 Exhibit 10.32 Summary of Non-Employee Director Compensation The following summary describes the individual components of the non-employee director compensation of Ingredion Incorporated (the "Company") in 2023. Effective January 1, 2023, each non-employee director is entitled to an annual retainer of $250,000 (no change from the prior year), which is c
February 21, 2023	EX-10.10	Form of 2023 Stock Option Award Agreement for use in connection with awards under the Stock Incentive Plan (incorporated by reference to Exhibit 10.10 to Ingredion’s Annual Report on Form 10-K for the year ended December 31, 2022, filed on February 21, 2023) (File No. 1-13397). EXHIBIT 10.10 Ingredion Incorporated Stock Incentive Plan Global Stock Option Award Agreement Ingredion Incorporated (the “Company”) has granted you a Non-Qualified Stock Option (the “Option”) under the Ingredion Incorporated Stock Incentive Plan (the “Plan”). The Option grant date, the shares of Company Common Stock (“Shares”) covered by the Option, and the Option exercise price are set forth in
February 21, 2023	EX-10.20	Form of 2023 Restricted Stock Units Award Agreement for use in connection with awards under the Stock Incentive Plan (incorporated by reference to Exhibit 10.20 to Ingredion’s Annual Report on Form 10-K for the year ended December 31, 2022, filed on February 21, 2023) (File No. 1-13397). EXHIBIT 10.20 Ingredion Incorporated Stock Incentive Plan Global Restricted Stock Unit Award Agreement Ingredion Incorporated (the “Company”) has granted you an award of Restricted Stock Units (the “Award”) under the Ingredion Incorporated Stock Incentive Plan (the “Plan”). The Award represents the right to receive shares of Company Common Stock in the future. The grant date of the Award and the n
February 21, 2023	EX-10.27	Letter of Agreement, dated as of November 23, 2020, between Ingredion and Eric Seip (incorporated by reference to Exhibit 10.27 to Ingredion’s Annual Report on Form 10-K for the year ended December 31, 2022, filed on February 21, 2023) (File No. 1-13397). EX-10.27 8 ingr-20221231xex1027.htm EX-10.27 EXHIBIT 10.27 Ingredion Incorporated 5 Westbrook Corporate Center Westchester, IL 60154 PERSONAL & CONFIDENTIAL November 23, 2020 Eric Seip Delivered electronically Dear Eric: Congratulations! I am pleased to confirm our offer of employment to join Ingredion Incorporated in the position of Senior Vice President, Global Operations, with an anticipated st
February 21, 2023	EX-10.28	Letter of Agreement, dated as of April 15, 2020, between Ingredion and Jeremy Xu. EXHIBIT 10.28 Ingredion Incorporated 5 Westbrook Corporate Center Westchester, IL 60154 PERSONAL & CONFIDENTIAL April 15, 2020 Jeremy Xu Delivered electronically Dear Jeremy: Congratulations! I am pleased to confirm our offer of employment to join Ingredion Incorporated in the position of Chief Innovation Officer and President Sweetener Specialties, with an anticipated start date of no later than
February 21, 2023	EX-10.30	Amendment No. 1 to Revolving Credit Agreement, dated as of November 30, 2022, by and among Ingredion Incorporated, as Borrower, the Subsidiary Borrowers from time-to-time party thereto, the Lenders from time-to-time party thereto and JP Morgan Chase Bank, N.A., as Administrative Agent. ingredion2022amendmentno 750807596.5 EXECUTION VERSION AMENDMENT NO. 1 Dated as of November 30, 2022 to REVOLVING CREDIT AGREEMENT Dated as of June 30, 2021 THIS AMENDMENT NO. 1 (this “Amendment”) is made as of November 30, 2022 by and among Ingredion Incorporated, a Delaware corporation (the “Company”), the Lenders party hereto and JPMorgan Chase Bank, N.A., as Administrative Agent (the “Administ
February 21, 2023	EX-21.1	Subsidiaries of the Registrant EXHIBIT 21.1 SUBSIDIARIES OF THE REGISTRANT The Registrant’s subsidiaries as of December 31, 2022, are listed below showing the percentage of voting securities directly or indirectly owned by the Registrant. All other subsidiaries, if considered in the aggregate as a single subsidiary, would not constitute a significant subsidiary. Percentage of voting securities directly or indirectly owned by th
February 21, 2023	EX-24.1	Power of Attorney EXHIBIT 24.1 INGREDION INCORPORATED POWER OF ATTORNEY Form 10-K for the Fiscal Year Ended December 31, 2022 KNOW ALL MEN BY THESE PRESENTS, that I, as a director of Ingredion Incorporated, a Delaware corporation (the “Company”), do hereby constitute and appoint Tanya M. Jaeger de Foras as my true and lawful attorney-in-fact and agent, for me and in my name, place and stead, to sign the Annual Repo
February 9, 2023	SC 13G/A	INGR / Ingredion Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: Ingredion Inc. Title of Class of Securities: Common Stock CUSIP Number: 457187102 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rul
February 8, 2023	EX-99	INGREDION INCORPORATED REPORTS 13% NET SALES GROWTH IN THE FOURTH QUARTER AND STRONG FULL-YEAR 2022 RESULTS Exhibit 99 NEWS RELEASE Ingredion Incorporated 5 Westbrook Corporate Center CONTACTS: Westchester, IL 60154 Investors: Noah Weiss, 773-896-5242 Media: Becca Hary, 708-551-2602 INGREDION INCORPORATED REPORTS 13% NET SALES GROWTH IN THE FOURTH QUARTER AND STRONG FULL-YEAR 2022 RESULTS •Fourth quarter 2022 reported and adjusted EPS* were $1.
February 8, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 8, 2023 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
January 24, 2023	SC 13G/A	INGR / Ingredion Inc / BlackRock Inc. Passive Investment SC 13G/A 1 us4571871023012423.txt us4571871023012423.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 13) INGREDION INCORPORATED - (Name of Issuer) Common Stock - (Title of Class of Securities) 457187102 - (CUSIP Number) December 31, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriat
December 16, 2022	EX-10.1	Credit Agreement, dated as of December 16, 2022, between Ingredion Incorporated, as borrower, and PNC Bank, National Association, as lender. Exhibit 10.1 EXECUTION VERSION CREDIT AGREEMENT dated as of December 16, 2022 between INGREDION INCORPORATED and PNC BANK, NATIONAL ASSOCIATION TABLE OF CONTENTS Page ARTICLE I Definitions 1 SECTION 1.01. Defined Terms 1 SECTION 1.02. Reserved 18 SECTION 1.03. Terms Generally 18 SECTION 1.04. Accounting Terms; GAAP 18 SECTION 1.05. Interest Rates; Benchmark Notification 19 SECTION 1.06. Exchange R
December 16, 2022	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2022 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission
November 7, 2022	EX-3.2	Amended and Restated By-Laws of Ingredion, as amended and restated on September 22, 2022. EXHIBIT 3.2 ? 4857-6646-2510v.8 AMENDED AND RESTATED BY-LAWS OF INGREDION INCORPORATED (the ?Corporation?) ? ? ARTICLE I Offices ? SECTION 1.The registered office of the Corporation in the State of Delaware shall be in the City of Wilmington, County of New Castle, and the name of the registered agent of the Corporation in said State is The Corporation Trust Company. The Corporation may also have a
November 7, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
November 3, 2022	EX-99.1	Ingredion Incorporated Reports Continued Strong Growth in Third Quarter 2022 Exhibit 99.1 NEWS RELEASE Ingredion Incorporated 5 Westbrook Corporate Center CONTACTS: Westchester, IL 60154 Investors: Noah Weiss, 773-896-5242 Media: Becca Hary, 708-551-2602 Ingredion Incorporated Reports Continued Strong Growth in Third Quarter 2022 ? Third quarter 2022 net sales of $2,023 million, 15% higher on a reported basis and 19% higher excluding foreign exchange impacts compared to th
November 3, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 3, 2022 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
September 27, 2022	S-3ASR	As filed with the Securities and Exchange Commission on September 27, 2022 Table of Contents As filed with the Securities and Exchange Commission on September 27, 2022 Registration No.
September 27, 2022	EX-25.1	Statement of Eligibility on Form T-1 under the Trust Indenture Act of 1939, as amended, of The Bank of New York Mellon Trust Company, N.A., as trustee with respect to the indenture filed as Exhibit 4.1 hereto Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ? CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. (Exact name of trustee as specified in its charter) 95-
September 27, 2022	EX-FILING FEES	Filing fee tables Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Ingredion Incorporated (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Regist
September 26, 2022	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2022 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission
September 23, 2022	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 22, 2022 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission
September 23, 2022	EX-3.2	Amended and Restated By-Laws of Ingredion Incorporated (marked copy showing changes to prior By-Laws of Ingredion Incorporated; unmarked copy). Exhibit 3.2 AMENDED AND RESTATED BY-LAWS OF INGREDION INCORPORATED ( December 9, 2016 the ?Corporation ?) ARTICLE I Offices SECTION 1. SECTION 1. The registered office of the Corporation in the State of Delaware shall be in the City of Wilmington, County of New Castle, and the name of the registered agent of the Corporation in said State is The Corporation Trust Company. The Corporation may also h
August 9, 2022	EX-99.1	Ingredion Incorporated Reports Strong Growth in Second Quarter 2022 Exhibit 99.1 NEWS RELEASE Ingredion Incorporated 5 Westbrook Corporate Center CONTACTS: Westchester, IL 60154 Investors: Jason Payant, 708-551-2584 Media: Becca Hary, 708-551-2602 Ingredion Incorporated Reports Strong Growth in Second Quarter 2022 ? Second quarter 2022 reported and adjusted EPS* were both $2.12, compared to second quarter 2021 reported and adjusted EPS of $2.62 and $2.05, respecti
August 9, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-1
August 9, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 9, 2022 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
June 28, 2022	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ? FORM 11-K ? ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? ? (Mark One) ? [X] Annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934 ? For the fiscal year ended December 31, 2021 or ? [ ] Transition report pursuant to Section 15(d) of the Securities
June 28, 2022	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D C.
June 2, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2022 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission File
June 2, 2022	EX-99	8:55 a.m. Welcome and Safety Overview Jason Payant, Vice President, Corporate Finance and Interim Vice President, Investor Relations 9 a.m. Executive Presentations 10:10 a.m. Management Q&A Session 10:30 a.m. Introduction to R&D Headquarters and Tour 2022 Investor Day Expanded solutions and opportunities to deliver healthy and sustainable growth Exhibit 99 8:55 a.
May 24, 2022	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2022 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission File
May 6, 2022	EX-10.1	Annual Incentive Plan, as amended and restated as of January 1, 2022. EXHIBIT 10.1 ? INGREDION INCORPORATED ANNUAL INCENTIVE PLAN EFFECTIVE JANUARY 1, 2022 Ingredion Incorporated (the ?Company?) has previously established and maintained the Company?s Annual Incentive Plan (the ?Plan?) and Short-Term Incentive Plan (?STIP?) for the benefit of eligible employees. The Company hereby amends and restates the Plan and the STIP in the form of this combined plan document ef
May 6, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
May 5, 2022	EX-99	Ingredion Incorporated Delivers Solid Growth in First Quarter 2022 17% net sales growth offset inflationary pressures contributing to strong year-over-year performance Exhibit 99 Ingredion Incorporated NEWS RELEASE 5 Westbrook Corporate Center Westchester, IL 60154 CONTACTS: Investors: Jason Payant, 708-551-2584 Media: Becca Hary, 708-551-2602 Ingredion Incorporated Delivers Solid Growth in First Quarter 2022 17% net sales growth offset inflationary pressures contributing to strong year-over-year performance ? First quarter 2022 reported and adjusted EPS* were $1.
May 5, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 5, 2022 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
April 7, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 7, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
February 24, 2022	8-K/A	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2021 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commissio
February 22, 2022	EX-24.1	Power of Attorney Exhibit 24.1 ? INGREDION INCORPORATED POWER OF ATTORNEY Form 10-K for the Fiscal Year Ended December 31, 2021 ? KNOW ALL MEN BY THESE PRESENTS, that I, as a director of Ingredion Incorporated, a Delaware corporation (the ?Company?), do hereby constitute and appoint Tanya Jaeger de Foras as my true and lawful attorney-in-fact and agent, for me and in my name, place and stead, to sign the Annual Rep
February 22, 2022	EX-21.1	Subsidiaries of the Registrant EXHIBIT 21.1 ? SUBSIDIARIES OF THE REGISTRANT ? The Registrant?s subsidiaries as of December 31, 2021, are listed below showing the percentage of voting securities directly or indirectly owned by the Registrant. All other subsidiaries, if considered in the aggregate as a single subsidiary, would not constitute a significant subsidiary. ? ? ? ? ? Percentage of voting securities directly or indirect
February 22, 2022	EX-10.7	Form of 2022 Stock Option Award Agreement for use in connection with awards under the Stock Incentive Plan (incorporated by reference to Exhibit 10.7 to Ingredion's Annual Report on Form 10-K for the year ended December 31, 2021, filed on February 22, 2022) (File No. 1-13397). Exhibit 10.7 Ingredion Incorporated Stock Incentive Plan 2022 Stock Option Award Agreement ? ? Ingredion Incorporated (the ?Company?) has granted you a Non-Qualified Stock Option (the ?Option?) under the Ingredion Incorporated Stock Incentive Plan (the ?Plan?). The Option grant date, the shares of Company Common Stock (?Shares?) covered by the Option, and the Option exercise price are set forth in
February 22, 2022	EX-10.16	Summary of Non-Employee Director Compensation. ? Exhibit 10.16 Summary of Non-Employee Director Compensation The following summary describes the individual components of the non-employee director compensation of Ingredion Incorporated (the "Company") in 2022. Effective January 1, 2022, each non-employee director is entitled to an annual retainer of $250,000 (an increase of $20,000 from the prior year), which is comprised of (i) an annual cash
February 22, 2022	EX-10.5	Annual Report on Form 10-K for the year ended December 31, 2021, filed on February 22, 2022) Exhibit 10.5 Ingredion Incorporated Stock Incentive Plan 2022 Performance Share Award Agreement Ingredion Incorporated (the ?Company?) has granted you an award of Performance Shares (the ?Award?) under the Ingredion Incorporated Stock Incentive Plan (the ?Plan?). This Award represents the right to receive shares of Company Common Stock in the future. The grant date of the Award and the number of P
February 22, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
February 22, 2022	EX-10.8	Form of 2022 Restricted Stock Units Award Agreement for use in connection with awards under the Stock Incentive Plan (incorporated by reference to Exhibit 10.8 to Ingredion's Annual Report on Form 10-K for the year ended December 31, 2021, filed on February 22, 2022) (File No. 1-13397). Exhibit 10.8 Ingredion Incorporated Stock Incentive Plan 2022 Restricted Stock Units Award Agreement ? ? Ingredion Incorporated (the ?Company?) has granted you an award of Restricted Stock Units (the ?Award?) under the Ingredion Incorporated Stock Incentive Plan (the ?Plan?). The Award represents the right to receive shares of Company Common Stock in the future. The grant date of the Award and the
February 10, 2022	SC 13G/A	INGR / Ingredion Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: Ingredion Inc. Title of Class of Securities: Common Stock CUSIP Number: 457187102 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ??Rul
February 3, 2022	EX-99	Ingredion Incorporated Reports 2021 Results Expects 7% to 9% Operating Income Growth for 2022 Exhibit 99 NEWS RELEASE Ingredion Incorporated 5 Westbrook Corporate Center Westchester, IL 60154 CONTACTS: Investors: Jason Payant, 708-551-2584 Media: Becca Hary, 708-551-2602 Ingredion Incorporated Reports 2021 Results Expects 7% to 9% Operating Income Growth for 2022 ? Fourth quarter 2021 reported and adjusted EPS* were $0.
February 3, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 3, 2022 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
February 1, 2022	SC 13G/A	INGR / Ingredion Inc / BlackRock Inc. Passive Investment us4571871023020122.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 12) INGREDION INCORPORATED - (Name of Issuer) Common Stock - (Title of Class of Securities) 457187102 - (CUSIP Number) December 31, 2021 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua
January 13, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 12, 2022 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission F
December 16, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2021 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission
November 15, 2021	8-K/A	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2021 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commissio
November 15, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2021 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission
November 5, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe
November 2, 2021	EX-99	Ingredion Incorporated Reports Third Quarter 2021 Results And Raises Full Year Adjusted Earnings Expectation Exhibit 99 Ingredion Incorporated 5 Westbrook Corporate Center NEWS RELEASE Westchester, IL 60154 CONTACTS: Investors: Jason Payant, 708-551-2584 Media: Becca Hary, 708-551-2602 Ingredion Incorporated Reports Third Quarter 2021 Results And Raises Full Year Adjusted Earnings Expectation ? Third quarter 2021 reported and adjusted EPS* were $1.
November 2, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 2, 2021 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
October 12, 2021	SC 13G/A	INGR / Ingredion Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Ingredion Inc. Title of Class of Securities: Common Stock CUSIP Number: 457187102 Date of Event Which Requires Filing of this Statement: September 30, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rul
August 25, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 20, 2021 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission Fi
August 19, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 17, 2021 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission Fi
August 6, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
August 3, 2021	EX-99	Ingredion Incorporated Reports Second Quarter 2021 Results EX-99 2 tm2123904d1ex99.htm EXHIBIT 99 Exhibit 99 NEWS RELEASE Ingredion Incorporated 5 Westbrook Corporate Center CONTACTS: Westchester, IL 60154 Investors: Tiffany Willis, 708-551-2592 Media: Becca Hary, 708-551-2602 Ingredion Incorporated Reports Second Quarter 2021 Results · Second quarter 2021 reported and adjusted EPS* were $2.62 and $2.05, respectively, compared to second quarter 2020 repor
August 3, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 3, 2021 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
July 1, 2021	8-K	Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2021 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission File
July 1, 2021	EX-10.1	Separation Agreement and General Release, dated June 25, 2021, by and between Janet M. Bawcom and Ingredion Incorporated Exhibit 10.1 SEPARATION AGREEMENT AND GENERAL RELEASE Janet M. Bawcom (?Executive?) and Ingredion Incorporated (?Ingredion? or the ?Company?) (collectively, the ?Parties?) hereby enter into this Separation Agreement and General Release (?Agreement?) and agree as follows: 1. Executive hereby voluntarily resigns from her position as Senior Vice President, General Counsel, Corporate Secretary, and Ch
July 1, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 25, 2021 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission File
July 1, 2021	EX-10.1	Revolving Credit Agreement, dated as of June 30, 2021, by and among Ingredion Incorporated, as Borrower, the Subsidiary Borrowers from time to time party thereto, the Lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent Exhibit 10.1 EXECUTION COPY REVOLVING CREDIT AGREEMENT dated as of June 30, 2021 among INGREDION INCORPORATED, The Subsidiary Borrowers Party Hereto, The Lenders Party Hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent, BANK OF AMERICA, N.A. and CITIBANK, N.A., as Syndication Agents and MIZUHO BANK, LTD., HSBC BANK USA, NATIONAL ASSOCIATION, TRUIST BANK, U.S. BANK NATIONAL ASSOCIATION, PNC
June 24, 2021	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ? FORM 11-K ? ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? ? (Mark One) ? [X] Annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934 ? For the fiscal year ended December 31, 2020 or ? [ ] Transition report pursuant to Section 15(d) of the Securities Exchange Act of
June 24, 2021	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D C.
May 27, 2021	S-8	As filed with the Securities and Exchange Commission on May 27, 2021 As filed with the Securities and Exchange Commission on May 27, 2021 Registration Statement No.
May 20, 2021	EX-10.1	Stock Incentive Plan as amended and restated as of May 19, 2021 (the "Stock Incentive Plan") (incorporated by reference to Exhibit 10.1 to Ingredion’s Current Report on Form 8-K dated May 20, 2021, filed on May 20, 2021) (File No. 1-13397). Exhibit 10.1 INGREDION INCORPORATED STOCK INCENTIVE PLAN (as amended by Board of Directors March 16, 2021, with share increase approved by Stockholders May 19, 2021) I. INTRODUCTION 1.1 Purpose. The purpose of the Ingredion Incorporated Stock Incentive Plan (the ?Plan?) is to promote the long-term financial success of Ingredion Incorporated (the ? Company?) by (i) attracting and retaining executiv
May 20, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2021 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission File
May 7, 2021	10-Q	Quarterly Report - 10-Q Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
May 7, 2021	EX-10.3	Form of Restricted Stock Units Award Agreement for use in connection with awards under the Stock Incentive Plan. ? ? Ingredion Incorporated Stock Incentive Plan 2021 Restricted Stock Units Award Agreement ? ? Ingredion Incorporated (the ?Company?) has granted you an award of Restricted Stock Units (the ?Award?) under the Ingredion Incorporated Stock Incentive Plan (the ?Plan?).
May 7, 2021	EX-10.2	Form of March 2021 Performance Share Award Agreement for use in connection with awards under the Stock Incentive Plan (incorporated by reference to Exhibit 10.2 to Ingredion's Quarterly Report on Form 10-Q for the quarter ended March 31, 2021, filed on May 7, 2021) (File No. 1-13397). Ingredion Incorporated Stock Incentive Plan 2021 Performance Share Award Agreement Ingredion Incorporated (the ?Company?) has granted you an award of Performance Shares (the ?Award?) under the Ingredion Incorporated Stock Incentive Plan (the ?Plan?).
May 4, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 4, 2021 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
May 4, 2021	EX-99	Ingredion Incorporated Reports First Quarter 2021 Results Exhibit 99 NEWS RELEASE Ingredion Incorporated Westbrook Corporate Center Westchester, IL 60154 CONTACTS: Investors: Tiffany Willis, 708-551-2592 Media: Becca Hary, 708-551-2602 Ingredion Incorporated Reports First Quarter 2021 Results ? First quarter 2021 reported and adjusted EPS* were $(3.
April 7, 2021	DEFA14A	- DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin
April 7, 2021	DEF 14A	Schedule 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14
March 18, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 16, 2021 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission Fil
March 18, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 16, 2021 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission Fil
March 18, 2021	EX-10.1	Second Amended and Restated Term Loan Credit Agreement, dated as of March 16, 2021, among Ingredion Incorporated, as Borrower, the Lenders party thereto and Bank of America, N.A., as Administrative Agent (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K dated March 18, 2021, filed on March 18, 2021 (File No. 1-13397)). Exhibit 10.1 Execution Version SECOND AMENDED AND RESTATED TERM LOAN CREDIT AGREEMENT dated as of March 16, 2021 among INGREDION INCORPORATED, as Borrower the Lenders Party Hereto, BANK OF AMERICA, N.A., as Administrative Agent and BofA SECURITIES, INC., as Sole Bookrunner and Sole Lead Arranger ARTICLE I DEFINITIONS 1 SECTION 1.01 Defined Terms 1 SECTION 1.02 Classification of Loans and Borrowing
February 24, 2021	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
February 24, 2021	EX-21.1	Subsidiaries of the Registrant EXHIBIT 21.1 ? SUBSIDIARIES OF THE REGISTRANT ? The Registrant?s subsidiaries as of December 31, 2020, are listed below showing the percentage of voting securities directly or indirectly owned by the Registrant. All other subsidiaries, if considered in the aggregate as a single subsidiary, would not constitute a significant subsidiary. ? ? ? ? ? Percentage of voting securities directly or indirect
February 24, 2021	EX-10.16	Summary of Non-Employee Director Compensation. EX-10.16 5 ingr-20201231xex10d16.htm EX-10.16 Exhibit 10.16 Summary of Non-Employee Director Compensation The following summary describes the individual components of the non-employee director compensation of Ingredion Incorporated (the "Company") in 2021. Effective January 1, 2021, each non-employee director is entitled to an annual retainer of $230,000 (no change from prior year) which is compri
February 24, 2021	EX-10.5	Form of February 2021 Performance Share Award Agreement for use in connection with awards under the Stock Incentive Plan (incorporated by reference to Exhibit 10.5 to Ingredion's Annual Report on Form 10-K for the year ended December 31, 2020, filed on February 24, 2021) (File No. 1-13397). Exhibit 10.5 Ingredion Incorporated Stock Incentive Plan 2021 Performance Share Award Agreement Ingredion Incorporated (the ?Company?) has granted you an award of Performance Shares (the ?Award?) under the Ingredion Incorporated Stock Incentive Plan (the ?Plan?). This Award represents the right to receive shares of Company Common Stock in the future. The grant date of the Award and the number of P
February 24, 2021	EX-10.6	Form of 2021 Stock Option Award Agreement for use in connection with awards under the Stock Incentive Plan (incorporated by reference to Exhibit 10.6 to Ingredion's Annual Report on Form 10-K for the year ended December 31, 2020, filed on February 24, 2021) (File No. 1-13397). EX-10.6 3 ingr-20201231xex10d6.htm EX-10.6 Exhibit 10.6 Ingredion Incorporated Stock Incentive Plan 2021 Stock Option Award Agreement Ingredion Incorporated (the “Company”) has granted you a Non-Qualified Stock Option (the “Option”) under the Ingredion Incorporated Stock Incentive Plan (the “Plan”). The Option grant date, the shares of Company Common Stock (“Shares”) covered by the Option, and the
February 24, 2021	EX-24.1	Power of Attorney EX-24.1 8 ingr-20201231xex24d1.htm EX-24.1 Exhibit 24.1 INGREDION INCORPORATED POWER OF ATTORNEY Form 10-K for the Fiscal Year Ended December 31, 2020 KNOW ALL MEN BY THESE PRESENTS, that I, as a director of Ingredion Incorporated, a Delaware corporation (the “Company”), do hereby constitute and appoint Janet M. Bawcom as my true and lawful attorney-in-fact and agent, for me and in my name, place
February 24, 2021	EX-10.7	Form of February 2021 Restricted Stock Units Award Agreement for use in connection with awards under the Stock Incentive Plan (incorporated by reference to Exhibit 10.7 to Ingredion's Annual Report on Form 10-K for the year ended December 31, 2020, filed on February 24, 2021) (File No. 1,13397). Exhibit 10.7 Ingredion Incorporated Stock Incentive Plan 2021 Restricted Stock Units Award Agreement ? Ingredion Incorporated (the ?Company?) has granted you an award of Restricted Stock Units (the ?Award?) under the Ingredion Incorporated Stock Incentive Plan (the ?Plan?). The Award represents the right to receive shares of Company Common Stock in the future. The grant date of the Award and the n
February 12, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Material Impairments UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2021 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission F
February 12, 2021	EX-99.1	GRUPO ARCOR AND INGREDION ANNOUNCE JOINT VENTURE IN ARGENTINA, CHILE AND URUGUAY Joint venture leverages manufacturing expertise, global go-to-market capabilities, and food and beverage industry experience to create and scale innovative ingredient so EX-99.1 Exhibit 99.1 NEWS RELEASE GRUPO ARCOR AND INGREDION ANNOUNCE JOINT VENTURE IN ARGENTINA, CHILE AND URUGUAY Joint venture leverages manufacturing expertise, global go-to-market capabilities, and food and beverage industry experience to create and scale innovative ingredient solutions Buenos Aires, Argentina and Westchester, Ill. (Feb. 12, 2021) - Grupo Arcor, the leading food company of Arg
February 10, 2021	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: Ingredion Inc. Title of Class of Securities: Common Stock CUSIP Number: 457187102 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule
February 3, 2021	EX-99	Ingredion Incorporated Reports Fourth Quarter and Full-Year 2020 Results Exhibit 99 NEWS RELEASE Ingredion Incorporated Westbrook Corporate Center Westchester, IL 60154 CONTACTS: Investors: Tiffany Willis, 708-551-2592 Media: Becca Hary, 708-551-2602 Ingredion Incorporated Reports Fourth Quarter and Full-Year 2020 Results · Fourth quarter 2020 reported and adjusted EPS* were $1.
February 3, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 3, 2021 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
January 29, 2021	SC 13G/A	SC 13G/A us4571871023012921.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 11) INGREDION INCORPORATED - (Name of Issuer) Common Stock - (Title of Class of Securities) 457187102 - (CUSIP Number) December 31, 2020 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua
November 6, 2020	EX-10.1	Letter of Agreement, dated as of June 30, 2020, between Ingredion and Jorgen Kokke (incorporated by reference to Exhibit 10.1 to Ingredion’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, filed on November 6, 2020) (File No, 1-13397). Exhibit 10.1 +1 708 551 2600 ingredion.com Ingredion Incorporated 5 Westbrook Corporate Center Westchester, Illinois 60154 United States t: +1 708 551 2600 w: ingredion.com PERSONAL & CONFIDENTIAL June 30th, 2020 Jorgen Kokke * * * Dear Jorgen, I am pleased to confirm your promotion to the position of Executive Vice President and President, Americas. The effective date of this promotion will be Oc
November 6, 2020	10-Q	Quarterly Report - 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe
November 2, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 1, 2020 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
November 2, 2020	EX-99	Ingredion Incorporated Reports Third Quarter 2020 Results Exhibit 99 Ingredion Incorporated NEWS RELEASE Westbrook Corporate Center Westchester, IL 60154 CONTACTS: Investors: Tiffany Willis, 708-551-2592 Media: Becca Hary, 708-551-2602 Ingredion Incorporated Reports Third Quarter 2020 Results · Third quarter 2020 reported and adjusted EPS* were $1.
August 5, 2020	10-Q	Quarterly Report - 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-1
August 4, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 4, 2020 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
August 4, 2020	EX-99	Ingredion Incorporated Reports Second Quarter 2020 Results Exhibit 99 NEWS RELEASE Ingredion Incorporated Westbrook Corporate Center Westchester, IL 60154 CONTACTS: Investors: Tiffany Willis, 708-551-2592 Media: Becca Hary, 708-551-2602 Ingredion Incorporated Reports Second Quarter 2020 Results · Second quarter 2020 reported and adjusted EPS* were $0.
July 24, 2020	11-K/A	- 11-K/A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K/A ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) [X] Annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2019 or [ ] Transition report pursuant to Section 15(d) of the Securities Exchange Act
July 1, 2020	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2020 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission File
June 22, 2020	11-K	- 11-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) [X] Annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2019 or [ ] Transition report pursuant to Section 15(d) of the Securities Exchange Act o
June 22, 2020	11-K	- 11-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D C.
June 8, 2020	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2020 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission File
May 22, 2020	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2020 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission File
May 13, 2020	EX-4.1	Tenth Supplemental Indenture, dated as of May 13, 2020, between Ingredion and The Bank of New York Mellon Trust Company, N.A. (as successor trustee to The Bank of New York), as Trustee (incorporated by reference to Exhibit 4.1 to Ingredion’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2020, filed on August 5, 2020) (File No. 1-13397). EX-4.1 Exhibit 4.1 INGREDION INCORPORATED as Issuer and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee Tenth Supplemental Indenture Dated as of May 13, 2020 $600,000,000 2.900% Senior Notes due June 1, 2030 TABLE OF CONTENTS Page Article 1 Relation to Indenture; Definitions; Rules of Construction Section 1.01. Relation to Indenture 1 Section 1.02. Definitions 1 Section 1.03. Rules of C
May 13, 2020	EX-1.1	Underwriting Agreement, dated May 8, 2020, between the Company and BofA Securities, Inc., Citigroup Global Markets Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein EX-1.1 Exhibit 1.1 INGREDION INCORPORATED $600,000,000 2.900% Senior Notes due 2030 $400,000,000 3.900% Senior Notes due 2050 UNDERWRITING AGREEMENT May 8, 2020 BofA Securities, Inc. One Bryant Park, 8th Floor New York, New York 10036 Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 As Representatives
May 13, 2020	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2020 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 1-13397 22-3514823 (State or other jurisdiction of incorporation) (Commission File N
May 13, 2020	EX-4.2	Eleventh Supplemental Indenture, dated as of May 13, 2020, between Ingredion and The Bank of New York Mellon Trust Company, N.A. (as successor trustee to The Bank of New York), as Trustee (incorporated by reference to Exhibit 4.2 to Ingredion’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2020, filed on August 5, 2020) (File No. 1-13397). EX-4.2 Exhibit 4.2 INGREDION INCORPORATED as Issuer and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee Eleventh Supplemental Indenture Dated as of May 13, 2020 $400,000,000 3.900% Senior Notes due June 1, 2050 TABLE OF CONTENTS Page Article 1 Relation to Indenture; Definitions; Rules of Construction Section 1.01. Relation to Indenture 1 Section 1.02. Definitions 1 Section 1.03. Rules o
May 11, 2020	424B2	CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered Amount to be registered Proposed maximum offering price per security Proposed maximum aggregate offering price Amount of registration fee(1) 2.900% Senior Notes due 20 424B2 Table of Contents Filed Pursuant to Rule 424(b)(2) Registration No. 333-233854 CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered Amount to be registered Proposed maximum offering price per security Proposed maximum aggregate offering price Amount of registration fee(1) 2.900% Senior Notes due 2030 $600,000,000 99.808% $598,848,000 $77,731 3.900% Senior Notes

CPO / - SEC-arkivering, Årsberetning, Fuldmagtserklæring

Grundlæggende statistik

SEC Filings

SEC Filings (Chronological Order)

How Much do you Like Fintel?

Write a Review and get 25% Off Your Next Purchase

How can we Improve?